HSBC Holdings
TXMD icon

HSBC Holdings’s TherapeuticsMD TXMD Stock Holding History

HSBC Holdings’s Portfolio TXMD Stock Details TXMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-452
Closed -$27K – 3176
2021
Q2 		$27K Buy
+452
New +$27.4K ﹤0.01% 2903
2021
Q1 		– Sell
-461
Closed -$28K – 3140
2020
Q4 		$28K Buy
+461
New +$31.5K ﹤0.01% 3003
2020
Q3 		– Sell
-534
Closed -$33K – 2868
2020
Q2 		$33K Sell
534
-113
-17% -$6.58K ﹤0.01% 2598
2020
Q1 		$34K Sell
647
-75
-10% -$7.44K ﹤0.01% 2593
2019
Q4 		$87K Sell
722
-69
-9% -$9.92K ﹤0.01% 2941
2019
Q3 		$144K Buy
791
+541
+216% +$76.3K ﹤0.01% 2934
2019
Q2 		$32K Sell
250
-31
-11% -$5.56K ﹤0.01% 2666
2019
Q1 		$68K Buy
+281
New +$74.3K ﹤0.01% 2643
2017
Q1 		– Sell
-517
Closed -$149K – 2585
2016
Q4 		$149K Buy
+517
New +$160K ﹤0.01% 2580

Other funds holding TXMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CWG
C WorldWide Group Copenhagen, Denmark $4.66B AUM 11.67% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

HSBC Holdings's TXMD Position: Q3 2021 in Review

HSBC Holdings sold out of TherapeuticsMD (TXMD) in Q3 2021, closing a stake of 452 shares — an estimated $27K sold.

HSBC Holdings first reported a position in TXMD in Q4 2016 and held it in 9 quarters. The position peaked at $149K in Q4 2016. 149 funds tracked by Wall St. Rank hold TXMD as of Q3 2021.

  • HSBC Holdings reported no remaining TherapeuticsMD position as of Q3 2021 after selling out during the quarter.
  • HSBC Holdings sold 452 TherapeuticsMD shares in Q3 2021, an estimated $27K.
  • HSBC Holdings first reported a position in TherapeuticsMD in Q4 2016 and held it in 9 quarters.
  • HSBC Holdings's TherapeuticsMD position peaked at $149K in Q4 2016.
  • 149 funds tracked by Wall St. Rank held TherapeuticsMD as of Q3 2021.

Based on HSBC Holdings's 13F filing for Q3 2021, filed 12 Nov 2021.